Overview

Eslicarbazepine Acetate Monotherapy Long Term Study

Status:
Completed
Trial end date:
2017-04-15
Target enrollment:
Participant gender:
Summary
This is a long term, open-label, safety extension study in subjects with partial onset seizures.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Eslicarbazepine acetate